The Future of Clinical Trials in Argentina

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

The Future of Clinical Trials in Argentina

The Future of Clinical Trials in Argentina – Biotech Clinical Trials

Clinical trials are at the forefront of medical research, enabling advancements in healthcare and improving patient outcomes. Argentina has emerged as a prominent destination for conducting clinical trials, boasting a robust healthcare system, a diverse patient population, and a favorable regulatory environment.

In this blog, we explore the current landscape of clinical trials in Argentina and shed light on the opportunities, advancements, and challenges that lie ahead, paving the way for a promising future in clinical research.

Regulatory Reforms and Streamlined Processes

Argentina has implemented significant regulatory reforms to enhance the efficiency and transparency of clinical trials. The National Administration of Drugs, Foods, and Medical Devices (ANMAT) oversees clinical trial regulations, ensuring participant safety and data integrity.

These reforms have streamlined approval processes, reduced bureaucracy, and provided clear guidelines, making Argentina an attractive destination for clinical research. The country’s commitment to aligning its regulations with international standards has facilitated collaboration with global sponsors, fostering the growth of clinical trials.

Expansion into Diverse Therapeutic Areas

Argentina’s clinical trial landscape has expanded beyond traditional therapeutic areas, encompassing a wide range of specialties. The country has become a hub for research in oncology, neurology, cardiology, and other medical disciplines.

This expansion not only benefits local patients by providing access to cutting-edge treatments but also contributes to global medical knowledge and advancements. Argentina’s diverse patient population allows for inclusive and representative clinical trials, ensuring that study outcomes can be extrapolated to a broader patient population.

Collaborations and International Partnerships

Collaborations between Argentine research institutions, pharmaceutical companies, and international organizations have played a crucial role in advancing clinical trials. These partnerships foster knowledge exchange, resource-sharing, and capacity building, driving the quality and impact of clinical research.

Collaborative efforts facilitate the introduction of innovative trial methodologies, promote interdisciplinary approaches, and enhance scientific excellence. These collaborations contribute to the growth of Argentina’s research ecosystem, strengthen infrastructure, and position the country as a global player in clinical trials.

The Future of Clinical Trials in Argentina

The Future of Clinical Trials in Argentina

The Future of Clinical Trials in Argentina

Technological Advancements and Digital Transformation

The future of clinical trials in Argentina is intricately linked with technological advancements and digital transformation. From electronic data capture systems to telemedicine and remote monitoring, technology revolutionizes the way clinical trials are conducted.

These innovations improve data accuracy, enhance patient engagement, and enable real-time data analysis, leading to more efficient and cost-effective trials. Argentina’s increasing adoption of technology, improved connectivity, and the digital literacy of its population provide a conducive environment for the integration of these advancements.

Patient-Centric Approaches and Real-World Data

The future of clinical trials in Argentina will prioritize patient-centric approaches and the integration of real-world data. Emphasizing patient engagement, patient-reported outcomes, and shared decision-making ensures that trials are aligned with patient needs and preferences.

Additionally, the inclusion of real-world data collected from routine clinical practice provides a more comprehensive understanding of treatment effectiveness, safety, and long-term outcomes. This approach not only improves patient care but also enhances the efficiency and relevance of clinical trials in Argentina.

Addressing Challenges and Ensuring Quality

While Argentina has made significant progress in clinical trials, challenges remain. Ensuring quality and upholding ethical standards are paramount. Continued investments in training programs for investigators and research staff, adherence to Good Clinical Practice (GCP) guidelines, and robust regulatory oversight are crucial to maintaining participant safety, data integrity, and the credibility of clinical research.

Collaboration between regulatory bodies, sponsors, and research institutions is essential to promote transparency, strengthen quality assurance measures, and foster a culture of continuous improvement.

Public Awareness and Community Engagement

Increasing public awareness and community engagement are vital for the future of clinical trials in Argentina. Educating the public about the importance of clinical research, its benefits, and the rights of participants will help build trust and dispel misconceptions. Engaging with communities to understand their needs, concerns, and cultural sensitivities will ensure that trials are designed with their best interests in mind.

Collaborative efforts between research institutions, healthcare providers, and patient advocacy groups can help disseminate accurate information, address concerns, and encourage participation in clinical trials. By fostering open dialogue and involving patients and the public in the research process, Argentina can create a more inclusive and patient-centered clinical trial ecosystem.


Argentina is poised to shape the future of clinical trials, leveraging its robust healthcare system, diverse patient population, favorable regulatory reforms, and technological advancements. With streamlined processes, collaborations, patient-centric approaches, and a focus on public engagement, Argentina has the potential to attract more international trials, drive innovation, and contribute significantly to medical research and healthcare advancements.

By addressing challenges, ensuring quality, promoting public awareness, and engaging communities, Argentina can unlock the full potential of clinical trials, leading to improved patient care, expanded treatment options, and a brighter future for healthcare in the country.

The Future of Clinical Trials in Argentina 

Artificial intelligence in clinical trials in Argentina

Source: World Courier

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

The Future of Clinical Trials in Argentina

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
The Future of Clinical Trials in Argentina

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

The Future of Clinical Trials in Argentina

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

The Future of Clinical Trials in Argentina

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

The Future of Clinical Trials in Argentina

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

The Future of Clinical Trials in Argentina

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
The Future of Clinical Trials in Argentina

The Cohortias Team

The Future of Clinical Trials in Argentina

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

The Future of Clinical Trials in Argentina

Network & Partnerships